Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy
Journal of Controlled Release · 2023-03 · 355 · 593-603
DOI: 10.1016/j.jconrel.2023.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-03. Verfasst von Hanmei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Coarse Cereal Processing, School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China. Hauptthemen laut MEDLINE: Liposomes, Protein Corona. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Nanocarriers entering the body are usually coated by plasma protein, leading to a protein "corona" easily recognized by tissues and cells. Adjusting the composition of protein coronas may be an efficient way to change the properties and behavior of nanoparticles in vivo. In this study, we modified doxorubicin-loaded liposomes (Lip/DOX) with an albumin-binding domain (ABD) to prepare nanoparticles (ABD-Lip/DOX) that can specifically bind to albumin and form albumin-based protein coronas in vivo for targeted tumor therapy. The prepared liposomes were spherical with a particle size of about 100 nm. After incubating the liposomes with rat serum, the albumin content was eight times higher on ABD-Lip than on control liposomes. ABD-Lip significantly inhibited adsorption of IgG and complement activation in rat serum in vitro, while corona-coated ABD-Lip was internalized to a significantly greater extent than corona-coated control liposomes. In addition, ABD-Lip showed longer blood circulation time, higher tumor accumulation and greater antitumor efficacy than control liposomes in mice bearing 4 T1 tumors, while both liposome formulations showed similar biocompatibility. These results confirm that adjusting the component of protein coronas around nanoparticles can improve their therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Coarse Cereal Processing, School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
- Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu 610106, China.
- School of Preclinical Medicine, Chengdu University, Chengdu, 610106, China.
- Key Disciplines of Clinical Pharmacy, Affiliated Hospital and Clinical Medical College of Chengdu University, Chengdu 610081, China.
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- Key Laboratory of Coarse Cereal Processing, School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China. Electronic address: zouliangcdu@126.com.
Zitieren
APA
Li, H., Yin, D., Liao, J., Wang, Y., Gou, R., Tang, C., Li, W., Liu, Y., Fu, J., Shi, S., & Zou, L. (2023). Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy. Journal of Controlled Release, 355, 593-603. https://doi.org/10.1016/j.jconrel.2023.02.004
Vancouver
Li H, Yin D, Liao J, Wang Y, Gou R, Tang C, et al. Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy. Journal of Controlled Release. 2023;355:593-603. doi:10.1016/j.jconrel.2023.02.004
BibTeX
@article{Li2023,
author = {Li, Hanmei and Yin, Dan and Liao, Jiaying and Wang, Yao and Gou, Rui and Tang, Chuane and Li, Wei and Liu, Yi and Fu, Jiao and Shi, Sanjun and Zou, Liang},
title = {Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy},
journal = {Journal of Controlled Release},
year = {2023},
volume = {355},
pages = {593--603},
doi = {10.1016/j.jconrel.2023.02.004}
}
EUVIMED